The information on the following website is intended for healthcare professionals only.
Are you a healthcare professional?
Obstacles may arise when starting a treatment; rest assured Triptodur cares.
Triptodur can be filled through network specialty pharmacy in 1 of 3 ways:
Submit a prescription for
Triptodur via eRx and select:
PANTHERx Rare Pharmacy
24 Summit Park Drive
Pittsburgh, PA 15275
Contact Triptodur Care
Program to submit a
prescription over the phone.
Call (833) 401-CARE
Monday to Friday,
8:00 a.m. – 8:00 p.m. ET
Download the Patient
Enrollment Form and fax to
Triptodur can also be purchased direct via Specialty Distributors.
For more information, or claims support, call the
(833) 401-CARE, 8:00 a.m. - 8:00 p.m. ET, Monday to Friday.
Your patients can save up to $10,000 off their out-of-pocket cost each calendar year (after they pay the first $5 for each fill).
Terms and Conditions
By using Triptodur Copay Assistance, you certify that you currently meet the eligibility criteria and will comply with the Terms and Conditions described below:
TRIPTODUR is indicated for the treatment of pediatric patients 2 years of age and older with central precocious puberty (CPP).
IMPORTANT SAFETY INFORMATION
TRIPTODUR is contraindicated in:
Warnings and Precautions
Initial Rise of Gonadotropins and Sex Steroid Levels - During the early phase of therapy, gonadotropins and sex steroids rise above baseline because of the initial stimulatory effect of the drug. Therefore, a transient increase in clinical signs and symptoms of puberty, including vaginal bleeding, may be observed during the first weeks of therapy or after subsequent doses.
Psychiatric Events - Psychiatric events have been reported in patients taking GnRH agonists. Postmarketing reports with this class of drugs include symptoms of emotional lability, such as crying, irritability, impatience, anger, and aggression. Monitor for development or worsening of psychiatric symptoms during treatment with TRIPTODUR.
Convulsions - Postmarketing reports of convulsions have been observed in patients receiving GnRH agonists, including triptorelin. These included patients with a history of seizures, epilepsy, cerebrovascular disorders, central nervous system anomalies or tumors, and patients on concomitant medications that have been associated with convulsions such as bupropion and SSRIs. Convulsions have also been reported in patients in the absence of any of the conditions mentioned above.
In clinical trials for TRIPTODUR, the most common adverse reactions (≥4.5%) are injection site reactions, menstrual (vaginal) bleeding, hot flush, headache, cough, and infections (bronchitis, gastroenteritis, influenza, nasopharyngitis, otitis externa, pharyngitis, sinusitis, and upper respiratory tract infection).
You are encouraged to report side effects of prescription drugs to Arbor Pharmaceuticals, LLC Medical Information at 1-866-516-4950 or to the FDA at www.fda.gov/medwatch or call 1-800-FDA-1088.
For additional safety information, please consult the TRIPTODUR full Prescribing Information.